Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Recent findings from the Women’s Health Initiative Trial regarding risks and benefits of estrogen-progestin (combined hormone replacement therapy) in healthy postmenopausal women (Institution-wide mailing of physician educational materials)

Recent findings from the Women’s Health Initiative Trial regarding risks and benefits of estrogen-progestin (combined hormone replacement therapy) in healthy postmenopausal women (Institution-wide mailing of physician educational materials). 2002.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.